Dr El Khoueiry On Evolving

Media Summary: This session was recorded during the Cholangiocarcinoma Foundation Annual Conference on May 2, 2026. At the ELCA meeting that there was a lot of discussion about some of the Website: Twitter: Facebook: LinkedIn: ...

Dr El Khoueiry On Evolving - Detailed Analysis & Overview

This session was recorded during the Cholangiocarcinoma Foundation Annual Conference on May 2, 2026. At the ELCA meeting that there was a lot of discussion about some of the Website: Twitter: Facebook: LinkedIn: ... Ghassan K. Abou-Alfa, MD; Catherine Frenette, MD; Anthony Ghassan K. Abou-Alfa, MD; Catherine Frenette, MD; A. Ruth He, MD, PhD; and Anthony

Photo Gallery

Dr. El-Khoueiry on Evolving Role of Immunotherapy in HCC

Anthony El-Khoueiry, MD, discusses the pipeline of products in development for HCC

AC26 - Looking Down the Pipeline, Anthony El-Khoueiry

Dr. El-Khoueiry on the Frontline Treatment Landscape in HCC

Dr. El-Khoueiry on the Role of Ramucirumab in Advanced HCC

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

Dr. El-Khoueiry Discusses Research on Biomarkers in HCC

Dr. El-Khoueiry on the Rationale for Evaluating Nivolumab in Advanced HCC

Anthony El-Khoueiry, MD, discusses impact of new data on HCC Standard of care over last few years

Dr. El-Khoueiry, USC October Researcher of the Month

Dr. El-Khoueiry on Immunotherapy Combinations in HCC

Dr. El-Khoueiry on Choosing Between Immunotherapy Agents and TKIs in HCC

View Detailed Profile

Dr. El-Khoueiry on Evolving Role of Immunotherapy in HCC

Dr. El-Khoueiry on Evolving Role of Immunotherapy in HCC

Anthony B.

Anthony El-Khoueiry, MD, discusses the pipeline of products in development for HCC

Anthony El-Khoueiry, MD, discusses the pipeline of products in development for HCC

Anthony

AC26 - Looking Down the Pipeline, Anthony El-Khoueiry

AC26 - Looking Down the Pipeline, Anthony El-Khoueiry

This session was recorded during the Cholangiocarcinoma Foundation Annual Conference on May 2, 2026.

Dr. El-Khoueiry on the Frontline Treatment Landscape in HCC

Dr. El-Khoueiry on the Frontline Treatment Landscape in HCC

Anthony B.

Dr. El-Khoueiry on the Role of Ramucirumab in Advanced HCC

Dr. El-Khoueiry on the Role of Ramucirumab in Advanced HCC

Anthony B.

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

At the ELCA meeting that there was a lot of discussion about some of the

Dr. El-Khoueiry Discusses Research on Biomarkers in HCC

Dr. El-Khoueiry Discusses Research on Biomarkers in HCC

Anthony B.

Dr. El-Khoueiry on the Rationale for Evaluating Nivolumab in Advanced HCC

Dr. El-Khoueiry on the Rationale for Evaluating Nivolumab in Advanced HCC

Anthony B.

Anthony El-Khoueiry, MD, discusses impact of new data on HCC Standard of care over last few years

Anthony El-Khoueiry, MD, discusses impact of new data on HCC Standard of care over last few years

Anthony

Dr. El-Khoueiry, USC October Researcher of the Month

Dr. El-Khoueiry, USC October Researcher of the Month

Congratulations to

Dr. El-Khoueiry on Immunotherapy Combinations in HCC

Dr. El-Khoueiry on Immunotherapy Combinations in HCC

Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: ...

Dr. El-Khoueiry on Choosing Between Immunotherapy Agents and TKIs in HCC

Dr. El-Khoueiry on Choosing Between Immunotherapy Agents and TKIs in HCC

Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: ...

Understanding Biology and Patient Subsets in HCC

Understanding Biology and Patient Subsets in HCC

Experts Richard Finn, MD, and Anthony

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Visit http://www.ecancer.org for omre

Second-Line Nivolumab in Liver Cancer

Second-Line Nivolumab in Liver Cancer

Ghassan K. Abou-Alfa, MD; Anthony

Growing Treatment Landscape in Liver Cancer

Growing Treatment Landscape in Liver Cancer

Ghassan K. Abou-Alfa, MD; Catherine Frenette, MD; Anthony

Frontline Clinical Trials in Liver Cancer

Frontline Clinical Trials in Liver Cancer

Ghassan K. Abou-Alfa, MD; Catherine Frenette, MD; A. Ruth He, MD, PhD; and Anthony

HCC: Multidisciplinary Decision-Making

HCC: Multidisciplinary Decision-Making

Ghassan K. Abou-Alfa, MD; Anthony

Sorafenib Following HCC Disease Recurrence

Sorafenib Following HCC Disease Recurrence

Anthony

Related Video Content

WebMD - Find Doctors Near You: Top Physician Directory information

Search for doctors in your area. Research providers by insurance, specialty & procedures. Check doctor ratings,...

Healthgrades | Find a Doctor - Doctor Reviews - Online Doctor … information

Healthgrades is the leading online resource for comprehensive information about physicians and hospitals.

Find a Doctor - Online Doctor Appointments and Reviews information

Find and compare doctors in your area using Doctor.com’s easy to use Find a Doctor tool. Read patient reviews. Search...

Zocdoc | Find a Doctor Near You | Book Doctors Online information

Find the right doctor, right now with Zocdoc. Read reviews from verified patients and book an appointment with a...

Find Doctors Near Me | Schedule Online | Healthline FindCare information

Find doctors near you with Healthline FindCare. Compare qualified providers, review insurance compatibility, read...